# Benitec Biopharma Inc. (BNTC)

> Source: Nexqual · https://nexqual.com/BNTC · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Benitec Biopharma Inc. (BNTC), nexqual.com/BNTC" · informational, not investment advice.

**Price:** USD 8.46 (+2.05% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 8.29 · day 8.34–8.76 · 52w 8.25–16.76 · market cap $295M · NCM

## Key facts
- Analysts: Buy (mean 1.86 on a 1–5 scale) (7 analysts), mean target USD 24.33 (range 17–32).
- Total return with dividends: 1Y -46.1% vs S&P 500 +18.1%; 5Y -86.1% vs S&P 500 +85.1%.
- Next earnings: 2026-11-12, EPS estimate USD -0.28, revenue estimate $0K.

## Analysts
Consensus Buy (mean 1.86 on a 1–5 scale), 7 analysts; mean target USD 24.33 (low 17, high 32).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-15 | Wedbush | Target raised | Outperform | $16 → $17 |
| 2026-07-28 | Wedbush | Initiated | Outperform | $16 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -46.1% | -86.1% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -46.2% | -32.6% |
| Volatility (annualized) | 61.5% | 82.8% |
| Max drawdown | -49.8% (Oct 2025→Oct 2026) | -96.5% (Oct 2021→Jul 2023) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/BNTC · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt